CASP9 and type 1 diabetes mellitus: Consistently, in a model of transgenic R619 non-obese diabetic (NOD) mice generated with the Clustered Regularly Interspaced Short Palindromic Repeats-Caspase 9 (CRISPR/Cas9) technology, T1D onset occurs earlier with higher penetrance and higher autoantibodies titers (32).